disease entities & substance profiles

51
DISEASE ENTITIES & SUBSTANCE PROFILES RNSG 2213 SUBSTANCE-RELATED DISORDERS

Upload: dexter-short

Post on 30-Dec-2015

27 views

Category:

Documents


0 download

DESCRIPTION

RNSG 2213 SUBSTANCE-RELATED DISORDERS. DISEASE ENTITIES & SUBSTANCE PROFILES. CNS DEPRESSANTS. ALCOHOL Some Facts. 5-7% of Americans are Alcoholics Every alcoholic touches lives of 5 people - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: DISEASE ENTITIES & SUBSTANCE PROFILES

DISEASE ENTITIES&

SUBSTANCE PROFILES

RNSG 2213 SUBSTANCE-RELATED DISORDERS

Page 2: DISEASE ENTITIES & SUBSTANCE PROFILES

CNS DEPRESSANTS

Page 3: DISEASE ENTITIES & SUBSTANCE PROFILES

ALCOHOL Some Facts

5-7% of Americans are Alcoholics 5-7% of Americans are Alcoholics Every alcoholic touches lives of 5 Every alcoholic touches lives of 5

people people A leading cause of death: from medical A leading cause of death: from medical

complications, accidents and suicidescomplications, accidents and suicidesFetal Alcohol Syndrome most common Fetal Alcohol Syndrome most common

cause of mental retardation in children cause of mental retardation in children Potentiates other CNS depressantsPotentiates other CNS depressantsAlcoholism underreported in women Alcoholism underreported in women

and older adultsand older adults

Page 4: DISEASE ENTITIES & SUBSTANCE PROFILES

Alcohol: IntoxicationMetabolism of alcohol is increased in

heavy drinkersWomen more easily intoxicated than men.Effects: CNS depression and Peripheral

vasodilationDecreased muscle tension, lowered

anxiety level, disinhibition, impaired judgment, sedation

Toxic effects: stupor, unconsciousness (including blackouts), coma, death Alcohol poisoning s/t large amount

consumed in short period of time

Page 5: DISEASE ENTITIES & SUBSTANCE PROFILES

Alcohol WithdrawalUsually develops 4-12 hours after

cessation or reduction of alcohol useRebound phenomenon (CNS irritability)

as drug effects wear off: increased anxiety, tension, psychomotor

activitysweats, tremors, tachycardia, increased

temp. and BPnausea, vomiting, diarrhea

Page 6: DISEASE ENTITIES & SUBSTANCE PROFILES

Alcohol Withdrawal, cont’dWithdrawal seizures may occur 7-48

hours after cessation or reductionAlcohol withdrawal delirium (also

known as Delirium Tremens or DTs) may occur 48-72 hours following cessation or reduction- agitation, terror, hallucinations

(A Belgian beer is named for this effect)

Page 7: DISEASE ENTITIES & SUBSTANCE PROFILES

Alcohol WithdrawalUse of validated withdrawal assessment

rating scale assists in objective description of withdrawal severity

Page 8: DISEASE ENTITIES & SUBSTANCE PROFILES

Validated withdrawal assessment scale: Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar)

Page 9: DISEASE ENTITIES & SUBSTANCE PROFILES

Alcohol: Interventions for WithdrawalSeizure precautions; anticonvulsants for

DT’sSuicide assessment and precautions, if

necessaryMedications: for withdrawal

Benzodiazepines e.g. chlordiazepoxide (Librium), oxazepam (Serax), diazepam (Valium). Administration may depend on withdrawal rating parameters.

Page 10: DISEASE ENTITIES & SUBSTANCE PROFILES

Alcohol: Interventions for RecoveryMedications to promote abstinence after

detox.disulfiram (Antabuse) = Aversive Therapy; produces unpleasant or even harmful effects when alcohol is consumed or absorbed in any form (in foods, fluids, cosmetics, medications, etc.).

naltrexone (ReVia) – opiate receptor antagonist-blocks the “high”

acamprosate (Campral) – reduces cravings

Page 11: DISEASE ENTITIES & SUBSTANCE PROFILES

Complications of Alcohol Dependence: PhysiologicEsophagitis and gastritis (ulcers,

hemorrhage)Sexual dysfunctionPancreatitisHepatitisLeukopeniaThrombocytopeniaPeripheral neuritis with LE numbness, pain

Page 12: DISEASE ENTITIES & SUBSTANCE PROFILES

ALCOHOLISM: COMPLICATIONSCirrhosis-liver becomes fibrotic,

fatty

complications include portal hypertension, ascites, esophageal varices and hepatic encephalopathy)

Page 13: DISEASE ENTITIES & SUBSTANCE PROFILES

Complications of Alcoholism due to Thiamine (B1) Deficiency

Korsakoff’s Syndrome: memory loss, amnesia, psychosis

Wernicke’s Encephalopathy: ataxia, muscle weakness, nystagmus and confusion

Often appear together = Wernicke-Korsakoff Syndrome

Page 14: DISEASE ENTITIES & SUBSTANCE PROFILES

Result of toxicity + nutritional deficiency

Alcoholic Cardiomyopathy

Page 15: DISEASE ENTITIES & SUBSTANCE PROFILES

SEDATIVES, HYPNOTICS AND ANXIOLYTICS BARBITURATES,BENZODIAZEPINES

•Commonly prescribed for sleep, anxiety, muscle spasms, etc.

• Also used illicitly, including• reducing effects of stimulant (esp.

amphetamine) abuse

• if other narcotics not available

•by sexual predators

Page 16: DISEASE ENTITIES & SUBSTANCE PROFILES

Sedatives, Hypnotics, or Anxiolytics Abuse and DependencePotentiate each other and alcoholProduce physiological dependenceProduce psychological dependenceCross-tolerance and cross-dependence

between CNS depressants

Page 17: DISEASE ENTITIES & SUBSTANCE PROFILES

Sedatives, Hypnotics and Anxiolytics: Dependence

Withdrawal sx.: anxiety, insomnia, nausea, seizures

Overdose and Fatal effects: respiratory depression, coma, death

Page 18: DISEASE ENTITIES & SUBSTANCE PROFILES

Interventions for Sedative W/DQuiet, calm environmentMonitor vital signsTaper dose gradually; may take weeks or

monthsSeizure precautions

Page 19: DISEASE ENTITIES & SUBSTANCE PROFILES

InhalentsInorganic and organic volatile substances-

usually cheap and readily availableIntoxication: CNS depression- elevated

mood (silly and happy) and excitability, possible sleepiness and confusion

Page 20: DISEASE ENTITIES & SUBSTANCE PROFILES

INHALANTS: Abuse and Dependence

Dangerous due to inability to control amount inhaled

Use is associated with CNS damageRespiratory irritation, distress and depressionGI distressMouth ulcersRenal and hepatic damage Death from asphyxiation or suffocation

Page 21: DISEASE ENTITIES & SUBSTANCE PROFILES
Page 22: DISEASE ENTITIES & SUBSTANCE PROFILES

OPIOIDSOPIUM and HEROINMORPHINECODEINESYNTHETIC MORPHINE

DERIVATIVES, e.g:OXYCODONE (OxyContin)HYDROMORPHONE

((Dilaudid)HYDROCODONE (Vicodin)MEPERIDINE (Demerol)

Page 23: DISEASE ENTITIES & SUBSTANCE PROFILES

OPIOID Abuse and DependenceActivate endorphins, reduce pain and anxietyMany routes of use: po, subcut., IM, IV, inhaledIV use is associated with infection, including

HIV and Hepatitis, bacterial endocarditis, and abscesses

May be prescribed or illicitly obtainedHeroin--highest abuse and dependence

potentialCNS effects, including respiratory depressionGI effects

Page 24: DISEASE ENTITIES & SUBSTANCE PROFILES

Opioid IntoxicationInitial euphoria Followed by apathy, dysphoria,

psychomotor agitation or retardationPupillary constrictionDrowsiness (“nodding”), slurred speechImpaired judgment, memory and

concentration

Page 25: DISEASE ENTITIES & SUBSTANCE PROFILES

Opioid Overdose Pinpoint pupils Clammy skin Respiratory

depression Coma (pupils will

dilate secondary to anoxia)

Death rapidly follows comaTX of Overdose: Narcotic

antagonist: naloxone (Narcan)

Page 26: DISEASE ENTITIES & SUBSTANCE PROFILES

Opioid Withdrawal

Very uncomfortable but rarely dangerous:• Dysphoria, anxiety, cravings• Sweating and chills, piloerection• Lacrimation, rhinorrhea• GI distress (anorexia, n/v, cramping, diarrhea)• Muscle aches, bone pain• Restlessness• Tremors• Sleep disturbances

Page 27: DISEASE ENTITIES & SUBSTANCE PROFILES

Interventions for Opioid Withdrawal

Primarily supportive careTreat symptomaticallySpecific pharmacotherapy:

clonidine-for n/v/diarrheabuprenorphine (Buprenex) –reduces

pain and discomfort

Page 28: DISEASE ENTITIES & SUBSTANCE PROFILES

Example of clinical assessment tool for opiate withdrawal (COWS)

Page 29: DISEASE ENTITIES & SUBSTANCE PROFILES

Interventions for Opioid DependenceMedications which Promote Abstinence:Maintenance Pharmacotherapy to reduce

cravings and block the “high” :naltrexone (Trexan, ReVia) methadone –requires enrollment in

maintenance program (federally controlled supervision)

Page 30: DISEASE ENTITIES & SUBSTANCE PROFILES

CNS STIMULANTS

Page 31: DISEASE ENTITIES & SUBSTANCE PROFILES

CNS STIMULANTS

CocaineAmphetamines: prescribed or illicit

Non-amphetamine stimulantsCaffeineNicotine

Page 32: DISEASE ENTITIES & SUBSTANCE PROFILES

STIMULANTS: Intoxication

Various Effects: Increased alertness, arousal and

enduranceDecreased need for food and sleepHR and BP

Page 33: DISEASE ENTITIES & SUBSTANCE PROFILES

Stimulants: Neurobiology

Different for different drugs:facilitate norepinephrine, dopamine

activitynicotinic receptor agonists

adenosine receptor antagonists

Page 34: DISEASE ENTITIES & SUBSTANCE PROFILES

STIMULANTS: COCAINEIntoxicationBlocks dopamine reuptake esp. in nucleus

accumbens (“pleasure center”)IV or intranasal route; Crack (dilute) form is

smokedRapid Effects and Rapidly metabolized:

Intense euphoriaIncreased mental alertnessIncreased motor and cardiac activityIncreased muscle strength

Page 35: DISEASE ENTITIES & SUBSTANCE PROFILES

Stimulants: Cocaine Dependence

Psychological dependence is even more severe than physical dependence; cravings are intense

Page 36: DISEASE ENTITIES & SUBSTANCE PROFILES

Stimulants: AMPHETAMINESIntoxication and DependenceOften are prescribed, widely abusedMethamphetamine: Slower metabolic

effects, often mixed with cocaine (cheaper)Routes: IV, intranasal, po, smokedImmediate intense pleasure, lasting high“Crash” occurs as drug effects wear offIntense cravings promote frequent,

repetitive use Damage to teeth, gums

Page 37: DISEASE ENTITIES & SUBSTANCE PROFILES

STIMULANTS: WITHDRAWAL AND COMPLICATIONSToxic effects: Hallucinations and paranoid

delusions Severe hypertension, cardiac ischemiaWithdrawal: severe agitation, anxiety,

depression Death from cardiac arrhythmias, seizures,

suicide, respiratory collapse, stroke

Page 38: DISEASE ENTITIES & SUBSTANCE PROFILES

STIMULANTS: Treatment of Overdose

• Induce vomiting, diuretics• Administer IM antipsychotic for drug-

induced psychosis/agitation

Page 39: DISEASE ENTITIES & SUBSTANCE PROFILES

HALLUCINOGENS

Page 40: DISEASE ENTITIES & SUBSTANCE PROFILES

HALLUCINOGENSNatural or synthetic substancesEffects vary from enhancement of sensory

stimuli to loss of reality and hallucinations (Psychotic symptoms)

Effects highly unpredictable

Page 41: DISEASE ENTITIES & SUBSTANCE PROFILES

HALLUCINOGENS: CANNABINOLS (MARIJUANA and Related)

Not strictly a hallucinogenMost widely used illegal drug in USActive Ingredient: THC (delta-9-

tetrahydrocannbinolDetectable in blood and urine for up to 4 weeks

Smoked or ingestedHashish-resinous form“Medical marijuana” antiemetic and for chronic

painLegal RX: drobinol (Marinol) Plant form legal in some states

Page 42: DISEASE ENTITIES & SUBSTANCE PROFILES

CANNABIS: INTOXICATION

Euphoria, relaxation, disinhibition Alteration in sensory and time perception Increased appetiteAnxiety Tachycardia and Hypotension

Page 43: DISEASE ENTITIES & SUBSTANCE PROFILES

CANNABIS: DEPENDENCE

?Physical?Psychological- tolerance

Page 44: DISEASE ENTITIES & SUBSTANCE PROFILES

CANNABIS: COMPLICATIONS AND ADVERSE EFFECTSImpaired memory, concentration Apathy and loss of motivation (heavy users)Pulmonary compromise?Reduced female, male hormones and sperm

count?Paranoia and panicFlashbacks

Page 45: DISEASE ENTITIES & SUBSTANCE PROFILES

HALLUCINOGENS: LYSERGIC ACID DIETHYLAMIDE (LSD)Semisynthetic-binds to serotonin

receptorsLSD Intoxication:

Episodic and binge use commonEffects last up to 12 hoursSynesthesia experiences-blending of

sensory perceptions

Page 46: DISEASE ENTITIES & SUBSTANCE PROFILES

LSD: ADVERSE EFFECTS

Hypertension and tachycardiaAcute psychosis: delusions, paranoiaFlashbacksPanic

Page 47: DISEASE ENTITIES & SUBSTANCE PROFILES

HALLUCINOGENS:PHENCYCLIDINE (PCP)•Synthetic anestheticPCP Intoxication:

Euphoria and relaxationPCP Adverse Effects:

Ataxia, vomitingAgitation, violent outbursts, catatoniaSevere elevations in HR and BP

Page 48: DISEASE ENTITIES & SUBSTANCE PROFILES

HALLUCINOGENS: LSD and PCPOverdose and Fatal effects; Complications Psychotic break (persisting psychosis)Perceptual distortions cause client to harm

self/suicide or othersCardiac arrestPCP-seizures

Page 49: DISEASE ENTITIES & SUBSTANCE PROFILES

HALLUCINOGENS: LSD and PCP

Psychological toleranceFrequent users-cravingsNo physiologic dependence

Page 50: DISEASE ENTITIES & SUBSTANCE PROFILES

LSD and PCPTreatment of Acute Intoxication or

OverdoseDiazepam (Valium) for seizures [PCP], paranoia

and panicIM haloperidol (Haldol) for agitation and

aggression

Page 51: DISEASE ENTITIES & SUBSTANCE PROFILES

Comparison Chart